Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-143

There is more news to come 

1 I suggest the more detail will be announced as they have time to look at the details of the latest results.

2 don’t forget

“In parallel, analyses have been continuing to assess the impact of BIT225 on HIV-1-induced immune activation. Data from this key component of the trial have been compiled, and are being reviewed by an independent, internationally renowned HIV immunologist based in Europe. It is expected that this review will be available at the same time as the results from the virology assay.”

So an internationally renowned hiv expert has yet to report....

this will be very significant!

i have been a holder for a very long time and have to remind myself after all the delays and disappointment that this is biotrons moment in the sun. 

MM get the data sorted let the expert present the view to the right audiences, get people looking at the right stuff and  report in your own time. 

I am looking forward to the AGM I will shake your hand, .

I think a few well placed phone calls to the people you would like to work with to make 225 real will make the next few weeks the best time you have had at BIT. 

I really hope the share price gets up to make the options work so you don’t have a need to do a capital collection too soon. You could get 20c a share if you get some pr and some talks going.

go find the white knight to help make this a reality.

i wish you all the very best. 

Please keep us up to speed, I was sick of being a mushroom.